CSL
The Principal Toxicologist at CSL Behring provides scientific leadership for nonclinical safety across multiple drug development projects, representing toxicology on interdisciplinary teams and leading the Nonclinical Expert Team (NCET). The role supports regulatory submissions and market authorization activities and contributes to strategy from early discovery through approval. It operates within a global biotherapeutics R&D organization focused on innovative therapies.
Headquarters
Melbourne, Victoria, Australia
Company Size
10001+ employees
Founded
1916
CSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL.
CSL didn’t post a salary, so this is our estimate from similar listings.
Director, Toxicology
Praxis Precision Medicines, Inc.
Director, Toxicology Translational Science
Tarsus Pharmaceuticals
Associate Director, Toxicology, Nonclinical Development (Program Toxicologist)
8a7882525b6027b0015b692822e001ab
Executive Director, Toxicology
Exelixis
Sr. Scientist (Project Toxicology)
Zoetis
Senior Vice President, Preclinical Toxicology
Nurix